IRINOTECAN HYDROCHLORIDE (Onivyde) Nursing Considerations

What is the generic name?

IRINOTECAN HYDROCHLORIDE

What is the Trade Name for IRINOTECAN HYDROCHLORIDE?

Onivyde

What are the Indications for IRINOTECAN HYDROCHLORIDE?

• 1 INDICATIONS AND USAGE ONIVYDE ¬Æ is indicated, in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. Limitation of Use: ONIVYDE is not indicated as a single agent for the treatment of patients with metastatic adenocarcinoma of the pancreas [see Clinical Studies (14) ] . ONIVYDE is a topoisomerase inhibitor indicated, in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. ( 1 ) Limitation of Use: ONIVYDE is not indicated as a single agent for the treatment of patients with metastatic adenocarcinoma of the pancreas. ( 1 )

References: https://open.fda.gov/